Man S - Search Results

1

Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle-Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer.

Pham E, Yin M, Peters CG, Lee CR, Brown D, Xu P, Man S, Jayaraman L, Rohde E, Chow A, Lazarus D, Eliasof S, Foster FS, Kerbel RS. Pham E, et al. Among authors: man s. Cancer Res. 2016 Aug 1;76(15):4493-503. doi: 10.1158/0008-5472.CAN-15-3435. Epub 2016 Jun 20. Cancer Res. 2016. PMID: 27325647

2

Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.

Man S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ, Bergers G, Kerbel RS. Man S, et al. Cancer Res. 2002 May 15;62(10):2731-5. Cancer Res. 2002. PMID: 12019144

3

Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategy.

Shaked Y, Emmenegger U, Francia G, Chen L, Lee CR, Man S, Paraghamian A, Ben-David Y, Kerbel RS. Shaked Y, et al. Among authors: man s. Cancer Res. 2005 Aug 15;65(16):7045-51. doi: 10.1158/0008-5472.CAN-05-0765. Cancer Res. 2005. PMID: 16103050

4

Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy.

Munoz R, Man S, Shaked Y, Lee CR, Wong J, Francia G, Kerbel RS. Munoz R, et al. Among authors: man s. Cancer Res. 2006 Apr 1;66(7):3386-91. doi: 10.1158/0008-5472.CAN-05-4411. Cancer Res. 2006. PMID: 16585158

5

Targeted anti-vascular endothelial growth factor receptor-2 therapy leads to short-term and long-term impairment of vascular function and increase in tumor hypoxia.

Franco M, Man S, Chen L, Emmenegger U, Shaked Y, Cheung AM, Brown AS, Hicklin DJ, Foster FS, Kerbel RS. Franco M, et al. Among authors: man s. Cancer Res. 2006 Apr 1;66(7):3639-48. doi: 10.1158/0008-5472.CAN-05-3295. Cancer Res. 2006. PMID: 16585189

6

Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.

Folkins C, Man S, Xu P, Shaked Y, Hicklin DJ, Kerbel RS. Folkins C, et al. Among authors: man s. Cancer Res. 2007 Apr 15;67(8):3560-4. doi: 10.1158/0008-5472.CAN-06-4238. Cancer Res. 2007. PMID: 17440065

7

On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.

Man S, Munoz R, Kerbel RS. Man S, et al. Cancer Metastasis Rev. 2007 Dec;26(3-4):737-47. doi: 10.1007/s10555-007-9087-6. Cancer Metastasis Rev. 2007. PMID: 17846863 Review.

8

Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.

Cruz-Munoz W, Man S, Xu P, Kerbel RS. Cruz-Munoz W, et al. Among authors: man s. Cancer Res. 2008 Jun 15;68(12):4500-5. doi: 10.1158/0008-5472.CAN-08-0041. Cancer Res. 2008. PMID: 18559492

9

Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens.

Cruz-Munoz W, Man S, Kerbel RS. Cruz-Munoz W, et al. Among authors: man s. Clin Cancer Res. 2009 Aug 1;15(15):4867-74. doi: 10.1158/1078-0432.CCR-08-3275. Epub 2009 Jul 21. Clin Cancer Res. 2009. PMID: 19622578 Free PMC article.

10

Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts.

Francia G, Man S, Lee CJ, Lee CR, Xu P, Mossoba ME, Emmenegger U, Medin JA, Kerbel RS. Francia G, et al. Among authors: man s. Clin Cancer Res. 2009 Oct 15;15(20):6358-66. doi: 10.1158/1078-0432.CCR-09-0931. Epub 2009 Oct 13. Clin Cancer Res. 2009. PMID: 19825954 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,168 results

Search Page

Filters